Ajooni Biotech Ltd
NSE:AJOONI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/FCFF
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Valuation Scenarios
If EV/FCFF returns to its 3-Year Average (8.6), the stock would be worth ₹2.75 (34% downside from current price).
| Scenario | EV/FCFF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 13.1 | ₹4.2 |
0%
|
| 3-Year Average | 8.6 | ₹2.75 |
-34%
|
| 5-Year Average | 8.6 | ₹2.75 |
-34%
|
| Industry Average | 38.9 | ₹12.42 |
+196%
|
| Country Average | 35.9 | ₹11.47 |
+173%
|
Forward EV/FCFF
Today’s price vs future free cash flow to firm
Peer Comparison
| Market Cap | EV/FCFF | P/E | ||||
|---|---|---|---|---|---|---|
| IN |
|
Ajooni Biotech Ltd
NSE:AJOONI
|
723.4m INR | 13.1 | 14.7 | |
| US |
A
|
Archer-Daniels-Midland Co
XETRA:ADM
|
31B EUR | 10.1 | 33.5 | |
| US |
|
Bunge Ltd
NYSE:BG
|
24.6B USD | -38.7 | 29.6 | |
| SG |
|
Wilmar International Ltd
SGX:F34
|
22.5B SGD | 13.6 | 12.4 | |
| CN |
|
Tongwei Co Ltd
SSE:600438
|
78.2B CNY | -8.3 | -9.4 | |
| MY |
S
|
Sime Darby Plantation Bhd
KLSE:SIMEPLT
|
42.9B MYR | 48.6 | 23.1 | |
| US |
|
Darling Ingredients Inc
NYSE:DAR
|
10.2B USD | 20.4 | 160.8 | |
| US |
|
Ingredion Inc
NYSE:INGR
|
7B USD | 15.1 | 9.6 | |
| MY |
|
IOI Corporation Bhd
KLSE:IOICORP
|
26.8B MYR | 61.7 | 16.8 | |
| MY |
K
|
Kuala Lumpur Kepong Bhd
KLSE:KLK
|
23.6B MYR | -3 206 317 | 24.1 | |
| CN |
|
New Hope Liuhe Co Ltd
SZSE:000876
|
39.3B CNY | 12.4 | 39.6 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 20.7 |
| Median | 35.9 |
| 70th Percentile | 64.8 |
| Max | 50 585.9 |
Other Multiples
Ajooni Biotech Ltd
Glance View
Ajooni Biotech Ltd. engages in the manufacturing, production, processing, and supply of cattle feed nutrients and animal health care supplements. The company is headquartered in Mohali, Punjab. The company went IPO on 2018-01-02. The firm's cattle feeds include Autus NURTURE CALF STARTER, Autus WINNER 10LTR, Autus HIFFER /GROWER, Autus ENERGY PLUS, Autus ECO- 5LTR and Autus BUFF POWER. The firm's feed supplements include CALTUS, 4U, LIVTUS, RUMITUS, Mustmin, AUTOVITA and others.
